Jaguar Health, Inc. balance sheet
At the end of fiscal 2025, Jaguar Health, Inc. had total assets of $38.3m, total liabilities of $57.0m and shareholders' equity of −$18.7m. It held $968,000 in cash against $42.5m of debt: net debt of $41.6m.
Balance sheet
| Fiscal year | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1 | 8 | 1 | 1 | 3 | 3 | 8 | 17 | 5 | 6 | 8 | 1 | 4 |
| Receivables | — | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 |
| Inventory | 0 | 0 | 0 | 2 | 3 | 2 | 3 | 5 | 7 | 9 | 10 | 9 | 7 |
| Total current assets | 4 | 8 | 3 | 4 | 8 | 10 | 18 | 28 | 22 | 28 | 32 | 20 | 18 |
| Goodwill | — | — | 0 | 5 | 5 | — | — | — | — | — | — | — | — |
| Total assets | 4 | 12 | 4 | 44 | 41 | 36 | 43 | 53 | 47 | 51 | 53 | 38 | 34 |
| Accounts payable | 1 | 1 | 1 | 7 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 9 | 5 |
| Deferred revenue (current) | 0 | 0 | 0 | 0 | — | — | — | — | — | — | 0 | 0 | 0 |
| Total current liabilities | 3 | 4 | 4 | 15 | 27 | 15 | 13 | 15 | 30 | 14 | 20 | 41 | 25 |
| Short-term debt | — | 2 | 2 | 2 | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | 4 | 2 | 11 | — | 0 | 12 | 25 | 18 | 31 | 24 | 15 | 2 |
| Total debt | 0 | 6 | 4 | 15 | 27 | 7 | 16 | 28 | 34 | 36 | 36 | 43 | 16 |
| Total liabilities | 5 | 8 | 6 | 26 | 27 | 16 | 26 | 41 | 49 | 46 | 44 | 57 | 29 |
| Shareholders' equity | −8 | 4 | −2 | 17 | 5 | 11 | 17 | 12 | −1 | 5 | 6 | −19 | 5 |
| Non-controlling interests and other (assets − liabilities − equity) | 7 | — | — | — | 9 | 10 | — | — | — | — | 2 | — | — |
| Net debt (negative = net cash) | −0 | −2 | 3 | 14 | 24 | 4 | 8 | 11 | 28 | 29 | 28 | 42 | 12 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1 | 2 | 1 | 1 | 1 | 2 | 0 | 0 |
| Inventory | 10 | 10 | 11 | 11 | 11 | 9 | 8 | 7 |
| Total current assets | 37 | 32 | 30 | 28 | 29 | 20 | 20 | 18 |
| Total assets | 58 | 53 | 51 | 48 | 49 | 38 | 37 | 34 |
| Accounts payable | 5 | 5 | 7 | 7 | 8 | 9 | 5 | 5 |
| Deferred revenue (current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current liabilities | 20 | 20 | 28 | 29 | 36 | 41 | 41 | 25 |
| Long-term debt | 22 | 24 | 18 | 11 | 8 | 15 | 11 | 2 |
| Total debt | 22 | 24 | 18 | 11 | 8 | 15 | 11 | 2 |
| Total liabilities | 43 | 44 | 48 | 41 | 45 | 57 | 53 | 29 |
| Shareholders' equity | 13 | 6 | 1 | 7 | 4 | −19 | −16 | 5 |
| Non-controlling interests and other (assets − liabilities − equity) | 2 | 2 | 2 | — | — | — | — | — |
Compare with peers
- Verrica Pharmaceuticals Inc. balance sheet
- Scilex Holding Co balance sheet
- Sunshine Biopharma Inc. balance sheet
- BGM Group Ltd. balance sheet
- IM Cannabis Corp. balance sheet
Head to head: JAGX vs VRCAJAGX vs SCLXJAGX vs SBFM
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies